Loading clinical trials...
Loading clinical trials...
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of ZofinTM for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
Zofin
Placebo
Locations
1
United States
Mayo Clinic
Phoenix, Arizona, United States
Start Date
November 15, 2023
Primary Completion Date
May 30, 2024
Completion Date
August 31, 2024
Last Updated
November 1, 2023
NCT07383896
NCT07509606
NCT07477600
NCT07462221
NCT07351929
NCT06717659
Lead Sponsor
ZEO ScientifiX, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions